Trade JBIO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Jade Biosciences, Inc. (JBIO) is trading at US$20.93, down 1.68% today as of Aug 28, 12:42 EDT. The company has a market capitalisation of US$1.36B. Over the past 52 weeks, JBIO has traded between US$6.91 and US$28.00. On Syfe you can trade JBIO with $0 commission and add it to your watchlist.
| Previous close | US$21.29 |
|---|---|
| Market cap | US$1.36B |
| 52-week range | US$6.91 – US$28.00 |
| Volume | 342.54K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Jade Biosciences, Inc.
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Year: 2025
Jade Biosciences to Receive up to $22 Million as Part of Licensing Deal With Paragon Therapeutics
Jul 2, 11:02 AM · MT Newswires
UBS Initiates Jade Biosciences at Buy With $45 Price Target
Jun 15, 9:54 AM · MT Newswires
Jade Biosciences, Inc. (JBIO) stock is trading at US$20.93, -1.68% from the previous close of US$21.29.
The market cap for Jade Biosciences, Inc. (JBIO) stock is approximately US$1.36B.
The 52-week high for Jade Biosciences, Inc. (JBIO) stock is US$28.00.
The 52-week low for Jade Biosciences, Inc. (JBIO) stock is US$6.91.
Jade Biosciences, Inc. (JBIO) does not currently pay a dividend.
Stay on top of JBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
